Streetbeat News

Products Services

ZTEK

Zentek has announced the launch of a wholly-owned subsidiary that will hold the exclusive, global licensing rights for all aptamer-based technology from its collaboration with McMaster University.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 11:27 am

SVRE

SaverOne 2014 Ltd. (NASDAQ:SVRE), a technology company specializing in transportation safety solutions, has won six new customers in the private bus fleet industry. This industry, particularly buses carrying school children, represents significant growth potential for SaverOne and has become a strategic focus for the company.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 11:11 am

OKYO

Okyo Pharma has announced the safety data profile for its ongoing OK-101 Phase 2 trial for dry eye disease. The patients continue in the study and double-blind procedures are still in effect until all patients complete the 12-week dosing duration. The company expects to release topline data in December.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 11:11 am

IBM

IBM has launched the next evolution of its Managed Detection and Response service offerings, incorporating new AI technologies. These technologies can automatically escalate or close up to 85% of alerts, thereby accelerating security response timelines for clients.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 11:08 am

CSTL

Castle Biosciences has announced a new study showing that its DecisionDx-melanoma outperforms a nomogram developed at the Memorial Sloan Kettering Cancer Center in predicting the risk of sentinel lymph node positivity in patients with cutaneous melanoma.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 11:07 am

APLS

Apellis Pharmaceuticals has announced preliminary U.S. revenues of approximately $74M for Syfovre (Pegcetacoplan Injection) in Q3 FY23. The company distributed approximately 37,000 commercial vials and 10,000 samples to physician practices during the quarter.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 11:06 am

AMWL

Amwell (NYSE:AMWL) has announced a collaboration with Nestlé Health Science to develop innovative digital solutions focused on nutrition. The aim is to help health organizations improve patients' overall health and improve clinical and financial outcomes.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 11:06 am

R

Ryder System, Inc. (NYSE:R) has expanded its multiclient warehouse network by adding a 400,000-square-foot distribution center in Aurora, Illinois. The new facility, which opened in August, is the latest addition to a six-building campus totaling 2.4 million square feet. The campus primarily serves shippers of consumer packaged goods.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 11:04 am

LGVN

Longeveron has announced positive topline results from its Phase 2a trial of Lomecel-b for mild Alzheimer's disease. The primary endpoint of safety was met across all study groups.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 11:04 am

NBIX

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) has announced positive top-line data from the Phase 3 CAHtalyst Pediatric Study evaluating the efficacy, safety, and tolerability of crinecerfont in children and adolescents with classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. Crinecerfont is an oral, selective corticotropin-releasing factor type 1 receptor antagonist being investigated to help reduce and control excess adrenal androgens through a steroid-independent mechanism.

Portfolio Pulse from Benzinga Newsdesk

October 05, 2023 | 11:03 am